News
The foundation behind Novo Nordisk A/S and the Danish government will invest €80 million ($93 million) in a Microsoft-powered ...
Novo Nordisk Foundation & Denmark invest €80M in a Microsoft-powered quantum computer to boost Nordic tech innovation.
The company will offer a generic version of semaglutide in the country after Novo Nordisk let its patent expire there. Hims & ...
Novo Nordisk reportedly failed to pay its annual fees to maintain the patent rights in Canada, opening the door to cheaper ...
1d
TipRanks on MSNNovo Nordisk’s IcoSema Study: A New Horizon in Diabetes TreatmentNovo Nordisk (($DE:NOVA)) announced an update on their ongoing clinical study. Novo Nordisk has completed a 40-week clinical study titled ‘A ...
To address this, EIFO and the Novo Nordisk Foundation are investing €80 million to establish QuNorth, a new Nordic quantum initiative. QuNorth's primary mission is to acquire and operate the world's ...
Clever Culture’s APAS is now on trial with Novo Nordisk, and if it delivers, this one machine could unlock a global pharma ...
Novo Nordisk's pipeline, especially the oral GLP-1 and Alzheimer’s trial, offers significant long-term upside. Click here to ...
Eli Lilly (LLY 0.40%) and Novo Nordisk (NVO 1.97%) are two phenomenal growth stocks that investors probably can't go wrong ...
Denmark's Novo Nordisk said on Tuesday it had submitted a new, higher dose of its obesity treatment Wegovy to the European ...
2d
Money Talks News on MSNAre Your Weight-Loss Drugs Real? Novo Nordisk Sounds Alarm on KnockoffsOne in eight Americans use GLP-1 weight-loss drugs, but are they getting the real thing? Novo Nordisk's dramatic exit from a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results